Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03013816 · ClinicalTrials.gov registry record · NA

Increasing Donor Designation Rates in Teenagers: Effectiveness of a Driver's Education Intervention

A NA study, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
611
Enrollment target

NCT03013816: Completed NA study, sponsored by Beth Israel Deaconess Medical Center.

NCT03013816 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 611 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03013816, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
611 participants
Enrollment target

Study Summary

Four aims were pursued: (1) Evaluate the effectiveness of video messaging on adolescent donor designations in comparison to a regionally-matched historical comparison group of adolescents; (2) Compare the differential effectiveness of three commonly-used donation messaging strategies (informational, testimonial, and blended) on donor designations; (3) Examine the impact of donation messaging on changes in secondary outcomes (donation engagement, knowledge, attitudes, beliefs, likelihood of donor designation, discussion with a parent) before and after video intervention; and (4) Assess the commitment of parents to follow their adolescent's donation wishes in the event of death. Our central hypotheses were that integrating donation video messaging into driver education classes would generate a higher proportion of donor designations compared to a historical comparison group and that blended video messaging (informational + testimonials) would yield a higher proportion of donor designations and more change in secondary outcomes.

Primary Outcome

The primary outcome was donor designation (yes-no) at time of obtaining first driver's license post-intervention. We provided the name, date of birth, last four digits of social security number, residential address, and study identification number of each adolescent to the Massachusetts DoT, which then returned to us a data file containing the donor designation status for each study identification number. For the regionally-matched historical comparison group, the DoT provided a de-identified da

Interventions

  • BEHAVIORAL Organ Donation Education: Testimonial Messaging
  • BEHAVIORAL Organ Donation Education: Informational Messaging
  • BEHAVIORAL Organ Donation Education: Blended Messaging

Trial Details

FieldValue
Enrollment Target 611 participants
Start Date 2015-06
Est. Completion 2018-10
Phase NA

What the finished NCT03013816 record still lists

NCT03013816 is an interventional study that assigns participants to a tested intervention. The registered 611 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower).

The record links to 0 conditions, and to 3 interventions - of which Organ Donation Education: Testimonial Messaging is the first listed.

NCT03013816 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03013816 about?

NCT03013816 is a clinical study titled "Increasing Donor Designation Rates in Teenagers: Effectiveness of a Driver's Education Intervention". Four aims were pursued: (1) Evaluate the effectiveness of video messaging on adolescent donor designations in comparison to a regionally-matched historical comparison group of adolescents; (2) Compare the differential effectiveness of three commonly-used donation messaging strategies (informational,...

What is the current status of trial NCT03013816?

This trial is currently completed. It is a NA study. The enrollment target is 611 participants. The study started on 2015-06. Estimated completion is 2018-10.

What interventions are being tested in trial NCT03013816?

The interventions under investigation include: Organ Donation Education: Testimonial Messaging (BEHAVIORAL), Organ Donation Education: Informational Messaging (BEHAVIORAL), Organ Donation Education: Blended Messaging (BEHAVIORAL).

Who is sponsoring clinical trial NCT03013816?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03013816's enrollment target sits among peer trials

611 161st of 2000 higher than 1,840 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04224493 · 612 participants · Phase 3

    A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

  • NCT04590326 · 612 participants · Phase 1

    A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

  • NCT06266416 · 612 participants · NA

    IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)

  • NCT03536312 · 610 participants · NA

    Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03013816, the US trial registry maintained by the National Library of Medicine. NCT03013816 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.